Wealth Enhancement Advisory Services LLC Increases Stock Position in Relx Plc (NYSE:RELX)

Wealth Enhancement Advisory Services LLC raised its stake in shares of Relx Plc (NYSE:RELX - Free Report) by 12.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 46,476 shares of the technology company's stock after acquiring an additional 5,081 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in Relx were worth $2,111,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of RELX. Private Trust Co. NA grew its holdings in shares of Relx by 19.2% in the fourth quarter. Private Trust Co. NA now owns 1,237 shares of the technology company's stock valued at $56,000 after acquiring an additional 199 shares in the last quarter. Sage Mountain Advisors LLC boosted its position in Relx by 5.1% in the fourth quarter. Sage Mountain Advisors LLC now owns 5,292 shares of the technology company's stock worth $240,000 after purchasing an additional 258 shares during the last quarter. DRW Securities LLC grew its stake in Relx by 5.9% in the 4th quarter. DRW Securities LLC now owns 4,652 shares of the technology company's stock valued at $211,000 after purchasing an additional 259 shares during the period. Kovitz Investment Group Partners LLC increased its position in shares of Relx by 3.4% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 8,159 shares of the technology company's stock valued at $371,000 after purchasing an additional 267 shares during the last quarter. Finally, Ascent Group LLC increased its position in shares of Relx by 2.0% during the 4th quarter. Ascent Group LLC now owns 14,024 shares of the technology company's stock valued at $637,000 after purchasing an additional 277 shares during the last quarter. 15.02% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on RELX. Wall Street Zen downgraded shares of Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. Barclays upgraded shares of Relx from an "equal weight" rating to an "overweight" rating in a research note on Friday, March 14th. Morgan Stanley reissued an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. Finally, The Goldman Sachs Group initiated coverage on shares of Relx in a report on Wednesday, March 26th. They issued a "buy" rating on the stock. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Buy".

Relx Stock Performance

Shares of RELX stock traded down $0.61 on Monday, hitting $53.08. 696,190 shares of the stock were exchanged, compared to its average volume of 730,903. The firm's 50 day moving average is $52.66 and its two-hundred day moving average is $49.78. Relx Plc has a one year low of $43.45 and a one year high of $56.33. The firm has a market capitalization of $97.97 billion, a PE ratio of 28.53, a P/E/G ratio of 2.73 and a beta of 0.84. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.